 | • レポートコード：MRC2301H142 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、237ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料では、2021年に1,713.17百万ドルであった世界のマイクロキャリア市場規模が、2022年に1,843.34百万ドルになり、2027年まで年平均7.77%で成長して2,684.84百万ドルに拡大すると予測しています。本資料は、マイクロキャリアの世界市場について調べ、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（消耗品、装置）分析、形態別（液状、粒子状、固形状）分析、培養別（2D、3D）分析、機能別（コラーゲン、電荷、成長因子、タンパク質合成）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、Becton, Dickinson and Company、ChemoMetec A/S、Cole-Parmer (Techne)、Corning Inc、Cytiva、Danaher Corporation、Entegris、Eppendorf、GE Healthcareなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のマイクロキャリア市場規模：製品別 - マイクロキャリア用消耗品の市場規模 - マイクロキャリア用装置の市場規模 ・世界のマイクロキャリア市場規模：形態別 - 液体における市場規模 - 粒子における市場規模 - 固体における市場規模 ・世界のマイクロキャリア市場規模：培養別 - 2D培養における市場規模 - 3D培養における市場規模 ・世界のマイクロキャリア市場規模：機能別 - コラーゲンにおける市場規模 - 電荷におけるにおける市場規模 - 成長因子における市場規模 - タンパク質合成における市場規模 ・世界のマイクロキャリア市場規模：地域別 - 南北アメリカのマイクロキャリア市場規模 アメリカのマイクロキャリア市場規模 カナダのマイクロキャリア市場規模 ブラジルのマイクロキャリア市場規模 … - アジア太平洋のマイクロキャリア市場規模 日本のマイクロキャリア市場規模 中国のマイクロキャリア市場規模 インドのマイクロキャリア市場規模 韓国のマイクロキャリア市場規模 台湾のマイクロキャリア市場規模 … - ヨーロッパ/中東/アフリカのマイクロキャリア市場規模 イギリスのマイクロキャリア市場規模 ドイツのマイクロキャリア市場規模 フランスのマイクロキャリア市場規模 ロシアのマイクロキャリア市場規模 … - その他地域のマイクロキャリア市場規模 ・競争状況 ・企業情報 |
The Global Microcarriers Market size was estimated at USD 1,713.17 million in 2021 and expected to reach USD 1,843.34 million in 2022, and is projected to grow at a CAGR 7.77% to reach USD 2,684.84 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Microcarriers to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Consumables and Equipment. The Consumables is further studied across Media, Microcarrier Beads, and Reagents. The Equipment is further studied across Accessories, Bioreactors, Cell Counters, Culture Vessels, and Filtration Systems.
Based on Form, the market was studied across Liquid, Particle, and Solid.
Based on Culture Type, the market was studied across 2D and 3D.
Based on Function, the market was studied across Collagen, Electrical Charge, Growth Factor, and Protein Synthesis.
Based on Application, the market was studied across Biologics Manufacturing, Cell Therapy, and Vaccine Manufacturing.
Based on End User, the market was studied across CRO & Research Institutes and Pharmaceutical and Biotechnology Companie.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Microcarriers market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Microcarriers Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Microcarriers Market, including Becton, Dickinson and Company, ChemoMetec A/S, Cole-Parmer (Techne), Corning Inc, Cytiva, Danaher Corporation, Entegris, Eppendorf, GE Healthcare, Hi-Media Laboratories, Lonza Group AG, Merck KGaA, Pall Corporation, RoosterBio, Inc., Sartorius AG, Sartorius Stedim Biotech (SSB), and Thermo Fisher Scientific.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Microcarriers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Microcarriers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Microcarriers Market?
4. What is the competitive strategic window for opportunities in the Global Microcarriers Market?
5. What are the technology trends and regulatory frameworks in the Global Microcarriers Market?
6. What is the market share of the leading vendors in the Global Microcarriers Market?
7. What modes and strategic moves are considered suitable for entering the Global Microcarriers Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for cell-based therapeutics
5.1.1.2. Government financial support for cell-based research
5.1.1.3. Growing preference for single-use technologies
5.1.2. Restraints
5.1.2.1. Limitation to the cell enumeration due to higher cell density
5.1.3. Opportunities
5.1.3.1. Increasing R&D efforts by biopharma companies
5.1.3.2. Potential applications in 3D cultures
5.1.4. Challenges
5.1.4.1. Challenges to harvest cells from macroporous carriers
5.2. Cumulative Impact of COVID-19
6. Microcarriers Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Media
6.3.2. Microcarrier Beads
6.3.3. Reagents
6.3. Equipment
6.4.1. Accessories
6.4.2. Bioreactors
6.4.3. Cell Counters
6.4.4. Culture Vessels
6.4.5. Filtration Systems
7. Microcarriers Market, by Form
7.1. Introduction
7.2. Liquid
7.3. Particle
7.4. Solid
8. Microcarriers Market, by Culture Type
8.1. Introduction
8.2. 2D
8.3. 3D
9. Microcarriers Market, by Function
9.1. Introduction
9.2. Collagen
9.3. Electrical Charge
9.4. Growth Factor
9.5. Protein Synthesis
10. Microcarriers Market, by Application
10.1. Introduction
10.2. Biologics Manufacturing
10.3. Cell Therapy
10.4. Vaccine Manufacturing
11. Microcarriers Market, by End User
11.1. Introduction
11.2. CRO & Research Institutes
11.3. Pharmaceutical and Biotechnology Companie
12. Americas Microcarriers Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Microcarriers Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Microcarriers Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Becton, Dickinson and Company
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. ChemoMetec A/S
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Cole-Parmer (Techne)
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Corning Inc
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Cytiva
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Danaher Corporation
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Entegris
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Eppendorf
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. GE Healthcare
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Hi-Media Laboratories
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Lonza Group AG
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Merck KGaA
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Pall Corporation
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. RoosterBio, Inc.
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Sartorius AG
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Sartorius Stedim Biotech (SSB)
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Thermo Fisher Scientific
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing